company background image
6645

Kim Forest Enterprise TPEX:6645 Stock Report

Last Price

NT$36.90

Market Cap

NT$1.5b

7D

0.1%

1Y

31.7%

Updated

07 Aug, 2022

Data

Company Financials
6645 fundamental analysis
Snowflake Score
Valuation4/6
Future Growth0/6
Past Performance3/6
Financial Health6/6
Dividends0/6

6645 Stock Overview

Kim Forest Enterprise Co., Ltd. provides precision medical products.

Kim Forest Enterprise Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Kim Forest Enterprise
Historical stock prices
Current Share PriceNT$36.90
52 Week HighNT$46.31
52 Week LowNT$22.35
Beta-0.44
1 Month Change2.61%
3 Month Change-6.85%
1 Year Change31.69%
3 Year Change118.43%
5 Year Changen/a
Change since IPO71.22%

Recent News & Updates

Shareholder Returns

6645TW BiotechsTW Market
7D0.1%-1.3%0.1%
1Y31.7%33.4%-14.4%

Return vs Industry: 6645 underperformed the TW Biotechs industry which returned 33.4% over the past year.

Return vs Market: 6645 exceeded the TW Market which returned -14.4% over the past year.

Price Volatility

Is 6645's price volatile compared to industry and market?
6645 volatility
6645 Average Weekly Movement8.5%
Biotechs Industry Average Movement5.9%
Market Average Movement5.1%
10% most volatile stocks in TW Market8.4%
10% least volatile stocks in TW Market2.5%

Stable Share Price: 6645 is more volatile than 90% of TW stocks over the past 3 months, typically moving +/- 9% a week.

Volatility Over Time: 6645's weekly volatility (9%) has been stable over the past year, but is still higher than 75% of TW stocks.

About the Company

FoundedEmployeesCEOWebsite
2004n/an/ahttps://www.kimforest.com

Kim Forest Enterprise Co., Ltd. provides precision medical products. It offers devices, reagents, and analysis pipelines to health care providers, which include screening tests for cancer and inherited diseases. The company also provides genetic testing, drug report, and monitoring tools for cancer patients; and a non-invasive genome-wide health assessment for healthy persons.

Kim Forest Enterprise Fundamentals Summary

How do Kim Forest Enterprise's earnings and revenue compare to its market cap?
6645 fundamental statistics
Market CapNT$1.49b
Earnings (TTM)NT$89.44m
Revenue (TTM)NT$600.67m

16.6x

P/E Ratio

2.5x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
6645 income statement (TTM)
RevenueNT$600.67m
Cost of RevenueNT$341.20m
Gross ProfitNT$259.47m
Other ExpensesNT$170.03m
EarningsNT$89.44m

Last Reported Earnings

Dec 31, 2021

Next Earnings Date

n/a

Earnings per share (EPS)2.22
Gross Margin43.20%
Net Profit Margin14.89%
Debt/Equity Ratio13.6%

How did 6645 perform over the long term?

See historical performance and comparison

Dividends

0.5%

Current Dividend Yield

9%

Payout Ratio
We’ve recently updated our valuation analysis.

Valuation

Is 6645 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

4/6

Valuation Score 4/6

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Below Fair Value

  • Significantly Below Fair Value

  • Analyst Forecast

Key Valuation Metric

Which metric is best to use when looking at relative valuation for 6645?

Other financial metrics that can be useful for relative valuation.

6645 key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue2.3x
Enterprise Value/EBITDA10.9x
PEG Ration/a

Price to Earnings Ratio vs Peers

How does 6645's PE Ratio compare to its peers?

6645 PE Ratio vs Peers
The above table shows the PE ratio for 6645 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyPEEstimated GrowthMarket Cap
Peer Average54.1x
4117 General Biologicals
34.6xn/aNT$1.5b
4195 Genomics BioSci & Tech.Ltd
60.5xn/aNT$1.1b
1780 Allied Biotech
100.9xn/aNT$1.3b
3164 GenMont Biotech Incorporation
20.4xn/aNT$2.2b
6645 Kim Forest Enterprise
16.6xn/aNT$1.5b

Price-To-Earnings vs Peers: 6645 is good value based on its Price-To-Earnings Ratio (16.6x) compared to the peer average (54.1x).


Price to Earnings Ratio vs Industry

How does 6645's PE Ratio compare vs other companies in the Asian Biotechs Industry?

Price-To-Earnings vs Industry: 6645 is good value based on its Price-To-Earnings Ratio (16.6x) compared to the TW Biotechs industry average (32.8x)


Price to Earnings Ratio vs Fair Ratio

What is 6645's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

6645 PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio16.6x
Fair PE Ration/a

Price-To-Earnings vs Fair Ratio: Insufficient data to calculate 6645's Price-To-Earnings Fair Ratio for valuation analysis.


Share Price vs Fair Value

What is the Fair Price of 6645 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: 6645 (NT$36.9) is trading below our estimate of fair value (NT$394.81)

Significantly Below Fair Value: 6645 is trading below fair value by more than 20%.


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.


Discover undervalued companies

Future Growth

How is Kim Forest Enterprise forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

Future Growth Score

0/6

Future Growth Score 0/6

  • Earnings vs Savings Rate

  • Earnings vs Market

  • High Growth Earnings

  • Revenue vs Market

  • High Growth Revenue

  • Future ROE


148.0%

Forecasted Pharmaceuticals & Biotech industry annual growth in earnings

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Kim Forest Enterprise has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Discover growth companies

  • Examine whether Kim Forest Enterprise is trading at an attractive price based on how much it is expected to earn in the future, and relative to its industry peers and the wider market.

Past Performance

How has Kim Forest Enterprise performed over the past 5 years?

Past Performance Score

3/6

Past Performance Score 3/6

  • Quality Earnings

  • Growing Profit Margin

  • Earnings Trend

  • Accelerating Growth

  • Earnings vs Industry

  • High ROE


15.4%

Historical annual earnings growth

Earnings and Revenue History

Quality Earnings: 6645 has high quality earnings.

Growing Profit Margin: 6645 became profitable in the past.


Past Earnings Growth Analysis

Earnings Trend: 6645 has become profitable over the past 5 years, growing earnings by 15.4% per year.

Accelerating Growth: 6645 has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.

Earnings vs Industry: 6645 has become profitable in the last year, making it difficult to compare its past year earnings growth to the Biotechs industry (-29%).


Return on Equity

High ROE: 6645's Return on Equity (16.6%) is considered low.


Discover strong past performing companies

Financial Health

How is Kim Forest Enterprise's financial position?

Financial Health Score

6/6

Financial Health Score 6/6

  • Short Term Liabilities

  • Long Term Liabilities

  • Debt Level

  • Reducing Debt

  • Debt Coverage

  • Interest Coverage

Financial Position Analysis

Short Term Liabilities: 6645's short term assets (NT$404.1M) exceed its short term liabilities (NT$133.7M).

Long Term Liabilities: 6645's short term assets (NT$404.1M) exceed its long term liabilities (NT$67.3M).


Debt to Equity History and Analysis

Debt Level: 6645 has more cash than its total debt.

Reducing Debt: 6645's debt to equity ratio has reduced from 78.9% to 13.6% over the past 5 years.

Debt Coverage: 6645's debt is well covered by operating cash flow (121.4%).

Interest Coverage: 6645's interest payments on its debt are well covered by EBIT (85.4x coverage).


Balance Sheet


Discover healthy companies

Dividend

What is Kim Forest Enterprise current dividend yield, its reliability and sustainability?

Dividend Score

0/6

Dividend Score 0/6

  • Notable Dividend

  • High Dividend

  • Stable Dividend

  • Growing Dividend

  • Earnings Coverage

  • Cash Flow Coverage


0.52%

Current Dividend Yield

Dividend Yield vs Market

Notable Dividend: 6645's dividend (0.52%) isn’t notable compared to the bottom 25% of dividend payers in the TW market (2.55%).

High Dividend: 6645's dividend (0.52%) is low compared to the top 25% of dividend payers in the TW market (6.64%).


Stability and Growth of Payments

Stable Dividend: 6645 is not paying a notable dividend for the TW market, therefore no need to check if payments are stable.

Growing Dividend: 6645 is not paying a notable dividend for the TW market, therefore no need to check if payments are increasing.


Earnings Payout to Shareholders

Earnings Coverage: 6645 is not paying a notable dividend for the TW market.


Cash Payout to Shareholders

Cash Flow Coverage: 6645 is not paying a notable dividend for the TW market.


Discover strong dividend paying companies

Management

How experienced are the management team and are they aligned to shareholders interests?


CEO

Kim Forest Enterprise has no CEO, or we have no data on them.


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

Kim Forest Enterprise Co., Ltd.'s employee growth, exchange listings and data sources


Key Information

  • Name: Kim Forest Enterprise Co., Ltd.
  • Ticker: 6645
  • Exchange: TPEX
  • Founded: 2004
  • Industry: Biotechnology
  • Sector: Pharmaceuticals & Biotech
  • Implied Market Cap: NT$1.487b
  • Shares outstanding: 40.30m
  • Website: https://www.kimforest.com

Number of Employees


Location

  • Kim Forest Enterprise Co., Ltd.
  • No. 97, Xintai 5th Road
  • 30th Floor
  • New Taipei City
  • 221
  • Taiwan

Listings


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2022/08/07 00:00
End of Day Share Price2022/08/05 00:00
Earnings2021/12/31
Annual Earnings2021/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.